Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 51

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 51
---
 least two annual meetings of shareholders
will generally be required to effect a change in a majority of our board of directors. Any amendment to the provision in our Articles
of Association dividing our directors into three classes and certain related provisions requires a vote of the holders of at least 65%
of the shares represented at the meeting and voting on the matter.

These and other similar provisions could delay, prevent or impede
an acquisition of us or our merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.

29

It may be difficult
to enforce a U. S. judgment against us and our officers and directors in Israel or the United States, to
assert U. S. securities laws claims in Israel or to serve process on our officers and directors.

We are incorporated in Israel. All of our executive officers and
the majority of our directors reside outside of the United States, and a significant portion of our assets and most of the assets of such
executive officers and directors are located outside of the United States. Therefore, a judgment obtained against us or any of our executive
officers and directors in the United States, including a judgment based on the civil liability provisions of the U. S. federal securities
laws, may not be collectible in the United States. It also may be difficult for you to effect service of process on these persons in the
United States or to assert U. S. securities law claims in original actions instituted in Israel or obtain a judgment based on the civil
liability provisions of U. S. federal securities laws. Israeli courts may refuse to hear a claim against us or our non-U. S. officers and
directors based on an alleged violation of U. S. securities laws reasoning that Israel is not the most appropriate forum in which to bring
such a claim. In addition, even if an Israeli court agrees to hear such a claim, it may determine that Israeli law and not U. S. law is
applicable to the claim. If U. S. law is found to be applicable, the content of applicable U. S. law must be proven as a fact by expert
witnesses, which can be a time consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There
is little binding case law in Israel that addresses the matters described above. Additionally, Israeli courts might not enforce judgments
obtained in the United States against us or our non-U. S. directors and executive